Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Invested Capital: 2009-2021

Historic Invested Capital for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $220.6 million.

  • Avadel Pharmaceuticals' Invested Capital fell 48.64% to $123.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $123.8 million, marking a year-over-year decrease of 48.64%. This contributed to the annual value of $220.6 million for FY2021, which is 24.04% down from last year.
  • Avadel Pharmaceuticals' Invested Capital amounted to $220.6 million in FY2021, which was down 24.04% from $290.5 million recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Invested Capital peaked at $290.5 million during FY2020, and registered a low of $85.8 million during FY2017.
  • Over the past 3 years, Avadel Pharmaceuticals' median Invested Capital value was $220.6 million (recorded in 2021), while the average stood at $201.2 million.
  • Its Invested Capital has fluctuated over the past 5 years, first spiked by 214.07% in 2020, then decreased by 24.04% in 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Invested Capital (Yearly) stood at $85.8 million in 2017, then skyrocketed by 38.18% to $118.6 million in 2018, then fell by 22.03% to $92.5 million in 2019, then spiked by 214.07% to $290.5 million in 2020, then dropped by 24.04% to $220.6 million in 2021.